Eli Lilly and Company (LLY) to Expand Insulin-Manufacturing Facilities  
10/31/2012 6:11:05 AM

Eli Lilly & Co. (LLY) plans to expand its Indianapolis insulin-manufacturing facilities in a multimillion-dollar investment to meet growing demand in the U.S.

This marks the first expansion to the drugmaker's Indianapolis manufacturing operations--making high-tech insulin cartridges--in more than 20 years, the company said.